New

Influenza Vaccines Market

2021

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines, Trivalent Vaccines); Virus Type (Influenza Virus Type A, Influenza Virus Type B); Age Group (Pediatrics, Adult) and Geography

| Report Code: TIPRE00004070 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Influenza Vaccines Market 2028 By Vaccine Type, Virus Type, Age Group and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Influenza is a viral infection of the respiratory system that causes fever, muscle aches, runny nose, cough, congestion, headaches, and fatigue in infected people. Types A, B, C, and D are the four types of influenza viruses. Human influenza viruses, such as type A and B influenza viruses, are primarily responsible for seasonal flu epidemics each year. The two subtypes of Type A viruses are named upon differences in two viral surface proteins called hemagglutinin (H) and neuraminidase (N). Infections of influenza type C cause a mild respiratory illness and do not spread epidemics, whereas influenza D viruses mostly affect cattle and do not cause illness in humans.

MARKET SCOPE



The "Global Influenza Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the influenza vaccines market with detailed market segmentation by vaccine type, virus type and age group. The report provides key statistics on the market status of the leading influenza vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on vaccine type the market is segmented as, quadrivalent vaccines, trivalent vaccines.
  • Based on virus type the market is segmented as, influenza virus type A, influenza virus type B.
  • Based on age group the market is segmented as, pediatrics, adult.

MARKET DYNAMICS


Drivers:



  • Rising in government initiatives to ensure well-being and good health of population.
  • Less side effects associated with influenza vaccines, advancements in existing vaccines, and development of novel vaccines.
  • Moreover, funding and investments by companies in R&D activities supplement the growth of the Influenza vaccine market.

Restraints:



  • However, stringent approval procedures for vaccines, long time period required for vaccine development are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza vaccines market in these regions.

IMPACT OF COVID-19 ON INFLUENZA VACCINES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the influenza vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from influenza vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the influenza vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Serum Institute of India Pvt. Ltd
  • Abbott
  • Seqirus
  • Sanofi
  • GlaxoSmithKline plc
  • Mylan N.V(Viatris)
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Merck Sharp and Dohme Corp
  • AstraZeneca
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Influenza Vaccines Market - By Vaccine Type
    1.3.2 Influenza Vaccines Market - By Virus Type
    1.3.3 Influenza Vaccines Market - By Age Group
    1.3.4 Influenza Vaccines Market - By Region
    1.3.4.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. INFLUENZA VACCINES MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. INFLUENZA VACCINES MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. INFLUENZA VACCINES MARKET - GLOBAL MARKET ANALYSIS
    6.1. INFLUENZA VACCINES - GLOBAL MARKET OVERVIEW
    6.2. INFLUENZA VACCINES - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE TYPE
    7.1. OVERVIEW
    7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
    7.3. QUADRIVALENT VACCINES
    7.3.1. Overview
    7.3.2. Quadrivalent Vaccines Market Forecast and Analysis
    7.4. TRIVALENT VACCINES
    7.4.1. Overview
    7.4.2. Trivalent Vaccines Market Forecast and Analysis
    8. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - VIRUS TYPE
    8.1. OVERVIEW
    8.2. VIRUS TYPE MARKET FORECASTS AND ANALYSIS
    8.3. INFLUENZA VIRUS TYPE A
    8.3.1. Overview
    8.3.2. Influenza Virus Type A Market Forecast and Analysis
    8.4. INFLUENZA VIRUS TYPE B
    8.4.1. Overview
    8.4.2. Influenza Virus Type B Market Forecast and Analysis
    9. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - AGE GROUP
    9.1. OVERVIEW
    9.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
    9.3. PEDIATRICS
    9.3.1. Overview
    9.3.2. Pediatrics Market Forecast and Analysis
    9.4. ADULT
    9.4.1. Overview
    9.4.2. Adult Market Forecast and Analysis

    10. INFLUENZA VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Influenza Vaccines Market Overview
    10.1.2 North America Influenza Vaccines Market Forecasts and Analysis
    10.1.3 North America Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
    10.1.4 North America Influenza Vaccines Market Forecasts and Analysis - By Virus Type
    10.1.5 North America Influenza Vaccines Market Forecasts and Analysis - By Age Group
    10.1.6 North America Influenza Vaccines Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Influenza Vaccines Market
    10.1.6.1.1 United States Influenza Vaccines Market by Vaccine Type
    10.1.6.1.2 United States Influenza Vaccines Market by Virus Type
    10.1.6.1.3 United States Influenza Vaccines Market by Age Group
    10.1.6.2 Canada Influenza Vaccines Market
    10.1.6.2.1 Canada Influenza Vaccines Market by Vaccine Type
    10.1.6.2.2 Canada Influenza Vaccines Market by Virus Type
    10.1.6.2.3 Canada Influenza Vaccines Market by Age Group
    10.1.6.3 Mexico Influenza Vaccines Market
    10.1.6.3.1 Mexico Influenza Vaccines Market by Vaccine Type
    10.1.6.3.2 Mexico Influenza Vaccines Market by Virus Type
    10.1.6.3.3 Mexico Influenza Vaccines Market by Age Group
    10.2. EUROPE
    10.2.1 Europe Influenza Vaccines Market Overview
    10.2.2 Europe Influenza Vaccines Market Forecasts and Analysis
    10.2.3 Europe Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
    10.2.4 Europe Influenza Vaccines Market Forecasts and Analysis - By Virus Type
    10.2.5 Europe Influenza Vaccines Market Forecasts and Analysis - By Age Group
    10.2.6 Europe Influenza Vaccines Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Influenza Vaccines Market
    10.2.6.1.1 Germany Influenza Vaccines Market by Vaccine Type
    10.2.6.1.2 Germany Influenza Vaccines Market by Virus Type
    10.2.6.1.3 Germany Influenza Vaccines Market by Age Group
    10.2.6.2 France Influenza Vaccines Market
    10.2.6.2.1 France Influenza Vaccines Market by Vaccine Type
    10.2.6.2.2 France Influenza Vaccines Market by Virus Type
    10.2.6.2.3 France Influenza Vaccines Market by Age Group
    10.2.6.3 Italy Influenza Vaccines Market
    10.2.6.3.1 Italy Influenza Vaccines Market by Vaccine Type
    10.2.6.3.2 Italy Influenza Vaccines Market by Virus Type
    10.2.6.3.3 Italy Influenza Vaccines Market by Age Group
    10.2.6.4 Spain Influenza Vaccines Market
    10.2.6.4.1 Spain Influenza Vaccines Market by Vaccine Type
    10.2.6.4.2 Spain Influenza Vaccines Market by Virus Type
    10.2.6.4.3 Spain Influenza Vaccines Market by Age Group
    10.2.6.5 United Kingdom Influenza Vaccines Market
    10.2.6.5.1 United Kingdom Influenza Vaccines Market by Vaccine Type
    10.2.6.5.2 United Kingdom Influenza Vaccines Market by Virus Type
    10.2.6.5.3 United Kingdom Influenza Vaccines Market by Age Group
    10.2.6.6 Rest of Europe Influenza Vaccines Market
    10.2.6.6.1 Rest of Europe Influenza Vaccines Market by Vaccine Type
    10.2.6.6.2 Rest of Europe Influenza Vaccines Market by Virus Type
    10.2.6.6.3 Rest of Europe Influenza Vaccines Market by Age Group
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Influenza Vaccines Market Overview
    10.3.2 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis
    10.3.3 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
    10.3.4 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Virus Type
    10.3.5 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Age Group
    10.3.6 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Influenza Vaccines Market
    10.3.6.1.1 Australia Influenza Vaccines Market by Vaccine Type
    10.3.6.1.2 Australia Influenza Vaccines Market by Virus Type
    10.3.6.1.3 Australia Influenza Vaccines Market by Age Group
    10.3.6.2 China Influenza Vaccines Market
    10.3.6.2.1 China Influenza Vaccines Market by Vaccine Type
    10.3.6.2.2 China Influenza Vaccines Market by Virus Type
    10.3.6.2.3 China Influenza Vaccines Market by Age Group
    10.3.6.3 India Influenza Vaccines Market
    10.3.6.3.1 India Influenza Vaccines Market by Vaccine Type
    10.3.6.3.2 India Influenza Vaccines Market by Virus Type
    10.3.6.3.3 India Influenza Vaccines Market by Age Group
    10.3.6.4 Japan Influenza Vaccines Market
    10.3.6.4.1 Japan Influenza Vaccines Market by Vaccine Type
    10.3.6.4.2 Japan Influenza Vaccines Market by Virus Type
    10.3.6.4.3 Japan Influenza Vaccines Market by Age Group
    10.3.6.5 South Korea Influenza Vaccines Market
    10.3.6.5.1 South Korea Influenza Vaccines Market by Vaccine Type
    10.3.6.5.2 South Korea Influenza Vaccines Market by Virus Type
    10.3.6.5.3 South Korea Influenza Vaccines Market by Age Group
    10.3.6.6 Rest of Asia-Pacific Influenza Vaccines Market
    10.3.6.6.1 Rest of Asia-Pacific Influenza Vaccines Market by Vaccine Type
    10.3.6.6.2 Rest of Asia-Pacific Influenza Vaccines Market by Virus Type
    10.3.6.6.3 Rest of Asia-Pacific Influenza Vaccines Market by Age Group
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Influenza Vaccines Market Overview
    10.4.2 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis
    10.4.3 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
    10.4.4 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Virus Type
    10.4.5 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Age Group
    10.4.6 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Influenza Vaccines Market
    10.4.6.1.1 South Africa Influenza Vaccines Market by Vaccine Type
    10.4.6.1.2 South Africa Influenza Vaccines Market by Virus Type
    10.4.6.1.3 South Africa Influenza Vaccines Market by Age Group
    10.4.6.2 Saudi Arabia Influenza Vaccines Market
    10.4.6.2.1 Saudi Arabia Influenza Vaccines Market by Vaccine Type
    10.4.6.2.2 Saudi Arabia Influenza Vaccines Market by Virus Type
    10.4.6.2.3 Saudi Arabia Influenza Vaccines Market by Age Group
    10.4.6.3 U.A.E Influenza Vaccines Market
    10.4.6.3.1 U.A.E Influenza Vaccines Market by Vaccine Type
    10.4.6.3.2 U.A.E Influenza Vaccines Market by Virus Type
    10.4.6.3.3 U.A.E Influenza Vaccines Market by Age Group
    10.4.6.4 Rest of Middle East and Africa Influenza Vaccines Market
    10.4.6.4.1 Rest of Middle East and Africa Influenza Vaccines Market by Vaccine Type
    10.4.6.4.2 Rest of Middle East and Africa Influenza Vaccines Market by Virus Type
    10.4.6.4.3 Rest of Middle East and Africa Influenza Vaccines Market by Age Group
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Influenza Vaccines Market Overview
    10.5.2 South and Central America Influenza Vaccines Market Forecasts and Analysis
    10.5.3 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
    10.5.4 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Virus Type
    10.5.5 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Age Group
    10.5.6 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Influenza Vaccines Market
    10.5.6.1.1 Brazil Influenza Vaccines Market by Vaccine Type
    10.5.6.1.2 Brazil Influenza Vaccines Market by Virus Type
    10.5.6.1.3 Brazil Influenza Vaccines Market by Age Group
    10.5.6.2 Argentina Influenza Vaccines Market
    10.5.6.2.1 Argentina Influenza Vaccines Market by Vaccine Type
    10.5.6.2.2 Argentina Influenza Vaccines Market by Virus Type
    10.5.6.2.3 Argentina Influenza Vaccines Market by Age Group
    10.5.6.3 Rest of South and Central America Influenza Vaccines Market
    10.5.6.3.1 Rest of South and Central America Influenza Vaccines Market by Vaccine Type
    10.5.6.3.2 Rest of South and Central America Influenza Vaccines Market by Virus Type
    10.5.6.3.3 Rest of South and Central America Influenza Vaccines Market by Age Group

    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    12. INFLUENZA VACCINES MARKET, KEY COMPANY PROFILES
    12.1. SERUM INSTITUTE OF INDIA PVT. LTD
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. ABBOTT
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. SEQIRUS
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. SANOFI
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. GLAXOSMITHKLINE PLC
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. MYLAN N.V( VIATRIS)
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. MITSUBISHI TANABE PHARMA CORPORATION
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. PFIZER INC.
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. MERCK SHARP AND DOHME CORP
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. ASTRAZENECA
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments

    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    - Serum Institute of India Pvt. Ltd
    - Abbott
    - Seqirus
    - Sanofi
    - GlaxoSmithKline plc
    - Mylan N.V(Viatris)
    - Mitsubishi Tanabe Pharma Corporation
    - Pfizer Inc.
    - Merck Sharp and Dohme Corp
    - AstraZeneca
    - Gamma Vaccines Pty Ltd
    - CSL Limited
    - Emergent BioSolutions Inc.
    - Biodiem
    TIPRE00004070
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.